Co-founder & Managing Director, ARCH Venture Partners
Pioneer in deep biotech and genomics company creation
Robert Nelsen is a co-founder and Managing Director of ARCH Venture Partners who has played a significant role in creating, sourcing, financing, and developing more than 150 companies, with over 50 reaching billion-dollar valuations. He focuses on disruptive technologies and partnering with founding teams to advance novel platform technologies. Notable investments include seeding Illumina, Juno Therapeutics, Alnylam, Beam Therapeutics, GRAIL, and Altos Labs. He holds an MBA from the University of Chicago and a BS in Economics and Biology from the University of Puget Sound.
Company creation around transformative biology and platform technologies, particularly in genomics, gene editing, and cell therapy.
Based in: Seattle, WA (North America)